| |
| |
|
| Insider
Information: |
Sommadossi Jean-Pierre |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,175,126 |
|
|
Indirect Shares
|
6,264,625 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$143,626 |
|
|
| Total
Shares |
8,439,751 |
|
|
| Total
Value |
$143,626 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Idenix Pharmaceuticals Inc |
IDIX |
President, CEO, Chairm... |
2008-09-16 |
2,058,569 |
2008-09-16 |
161,185 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
Director |
2018-06-25 |
0 |
2018-06-25 |
178,440 |
Premium* |
|
|
Atea Pharmaceuticals, Inc. |
AVIR |
|
2024-02-01 |
116,557 |
2024-02-01 |
5,925,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVIR |
Atea Pharmaceuticals, Inc... |
President, CEO, and Chairman |
• • – |
2024-02-01 |
4 |
AS |
$3.85 |
$218,819 |
D/D |
(56,910) |
116,557 |
0 |
- |
|
| AVIR |
Atea Pharmaceuticals, Inc... |
President, CEO, and Chairman |
• • – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
173,467 |
173,467 |
0 |
- |
|
| AVIR |
Atea Pharmaceuticals, Inc... |
President, CEO, and Chairman |
• • – |
2020-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
750,000 |
5,925,000 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
Director |
– • – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
87,839 |
178,440 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, Chairman |
• • – |
2008-09-16 |
4 |
D |
$8.00 |
$880,000 |
D/D |
(110,000) |
2,058,569 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, Chairman |
• • – |
2006-05-09 |
4 |
B |
$9.13 |
$91,300 |
D/D |
10,000 |
2,058,269 |
2.81 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, Chairman |
• • – |
2005-04-06 |
5 |
GD |
$0.00 |
$0 |
I/I |
159,345 |
0 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, Chairman |
• • – |
2004-08-26 |
4 |
OE |
$8.50 |
$371,875 |
D/D |
43,750 |
2,007,614 |
|
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, Chairman |
• • – |
2004-07-27 |
4 |
B |
$14.00 |
$89,096 |
D/D |
6,364 |
1,963,864 |
2.81 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, ChairmanOffice |
• • – |
2004-07-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
351,240 |
|
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President, CEO, ChairmanOffice |
• • – |
2004-07-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,957,500 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
